What is Jazz Pharmaceuticals's derivative assets?

Jazz Pharmaceuticals (JAZZ) reported derivative assets of $0 in Q1 2026.

How has Jazz Pharmaceuticals's derivative assets changed year-over-year?

Jazz Pharmaceuticals's derivative assets decreased by 100.0% year-over-year, from $6.85M to $0.

What is the long-term trend for Jazz Pharmaceuticals's derivative assets?

Over 4 years (2020 to 2025), Jazz Pharmaceuticals's derivative assets has grown at a -14.7% compound annual growth rate (CAGR), from $11.91M to $6.3M.

Jazz Pharmaceuticals JAZZ Derivative assets

Derivative assets at other companies

BiogenBIIB

——

ResMedRMD

——

Other financials

Income statement

See full

Revenue$1.1B+19.1%

Operating income$336.6M+702%

Net income$293.1M+417%

EPS (diluted)$4.43+391%

Balance sheet

See full

Cash & equivalents$667.5M-64.1%

Total debt$5.4B-0.1%

Total equity$4.5B+8.6%

Total assets$11.9B+2.8%

Cash flow

See full

Operating cash flow$408.2M-5.0%

CapEx$19.7M+41.7%

Free cash flow$388.5M-6.6%

Valuation

See full

Market cap$14.11B+54.4%

Enterprise value$18.85B+47.7%

P/S3.2×+0.9×

Profitability

See full

Operating margin-11.9%-28.1pp

Net margin-8.9%-20.5pp

FCF margin28.6%-8.6pp

Returns & leverage

See full

Return on equity-9.1%-21.2pp

Debt / equity1.2×-0.1×

Current ratio2×-1.3×

Where this comes from

Reported directly by Jazz Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:DerivativeAssets.

The official record: Jazz Pharmaceuticals’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Jazz Pharmaceuticals's derivative assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Jazz Pharmaceuticals's derivative assets?: Jazz Pharmaceuticals (JAZZ) reported derivative assets of $0 in Q1 2026.
How has Jazz Pharmaceuticals's derivative assets changed year-over-year?: Jazz Pharmaceuticals's derivative assets decreased by 100.0% year-over-year, from $6.85M to $0.
What is the long-term trend for Jazz Pharmaceuticals's derivative assets?: Over 4 years (2020 to 2025), Jazz Pharmaceuticals's derivative assets has grown at a -14.7% compound annual growth rate (CAGR), from $11.91M to $6.3M.